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Abstract
Background: Herpesviruses are not only infectious agents of worldwide distribution in humans,
but have also been demonstrated in various non-human primates as well. Seventy-eight gibbons
were subjected to serological tests by ELISA for herpes simplex virus type 1 (HSV-1), herpes
simplex virus type 2 (HSV-2), Epstein-Barr virus (EBV) and cytomegalovirus (CMV).
Results: The prevalence of IgG antibodies against HSV-1, HSV-2, EBV and CMV was 28.2%, 28.2%,
14.1% and 17.9%, respectively.
Conclusions: Antigenic cross-reactivity is expected to exist between the human herpesviruses
and gibbon herpesviruses. Gibbons have antibodies to human herpesviruses that may reflect
zoonotic infection with human herpesviruses or infection with indigenous gibbon herpesviruses.
Therefore, it is difficult to draw concrete conclusions from serological studies alone. Identification
should be based on further isolation and molecular characterization of viruses from seropositive
animals.
Background
Gibbons (Hylobates spp.) have become valuable animals
for zoological, medical and psychological research. Their
small size (the smallest of the anthropoids), ease of han-
dling and maintenance in captivity and their close phylo-
genetic relationship to humans represent only a few of
their desirable characteristics as laboratory animals. Gib-
bons are found throughout the tropical rainforest of
South and Southeast Asia, including Thailand, Malaysia
and Indonesia. Illegal pet trade is the main cause of the
decreasing gibbon population in Thailand. Since gibbons
were categorized as a conserved species in Thailand, hun-
dreds of appropriated and abandoned animals have been
handed over to the authorities of the Royal Forest Depart-
ment (RFD). An infectious disease screening process is
necessary to interrupt the spread of diseases, including
herpesvirus infection. Little is known regarding natural or
experimental herpesvirus infections in this interesting ar-
boreal primate and reports of outbreaks or natural disease
are still limited. Hence, screening is required to prevent
the spread of infectious diseases, including herpesvirus.
Herpesviruses have been isolated from a wide variety of
mammalian and non-mammalian species. The eight hu-
man herpesviruses, herpes simplex virus type 1 and 2
(HSV-1 and -2), varicella-zoster virus (VZV), Epstein-Barr
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virus (EBV), human cytomegalovirus (CMV), and human
herpesviruses-6, -7 and -8 (HHV-6, -7 and -8), represent a
significant public health problem worldwide. These virus-
es have been further classified as members of the alpha-
herpesvirus (HSV-1, HSV-2 and VZV), the beta-herpesvi-
rus (CMV, HHV-6 and HHV-7) and the gamma-herpesvi-
rus subgroups (EBV and HHV-8). The virus-host
relationship is characterized by the benign nature of HSV
infection in its usual host, man, and by the fatal disease it
causes in accidental hosts, such as the owl monkey or gib-
bon. Fatal infections caused by HSV have been document-
ed in gibbons, patas and colobus monkeys [1,2]. A natural
epizootic model of Herpesvirus hominis is splenectomized
gibbons, which clinically mimic the disease as it occurs in
man [3]. EBV causes 85% of infectious mononucleosis
cases, whereas CMV is responsible for most of the remain-
ing cases. Both are mainly transmitted via exchange of sa-
liva. Cells infected with human herpesviruses such as
CMV, HSV-1, HSV-2 and EBV express specific virus-encod-
ed receptors capable of binding the FC domain of IgG [4].
Three major approaches can be employed for herpesvirus
diagnosis. The first is isolation of virus from clinical spec-
imens using mammalian cell culture systems and subse-
quent identification by biological, biochemical and
immunological procedures. The second is by identifica-
tion of anti-herpesvirus antibodies in sera of infected in-
dividuals. A third method, PCR, can also be used to
amplify and sequence herpesvirus DNA. Although the
PCR technique is widely used to detect herpesviruses, we
did not utilize it for this study due to the high costs. Since
clinical specimens are often unavailable, the first ap-
proach is not always possible; the second approach is
therefore more routinely used.
In this study, our objective was to determine whether
there is evidence of herpesvirus infection in gibbons.
Since test kits for gibbon herpesviruses are not currently
available, the serological tests were performed using hu-
man HSV-1, HSV-2, EBV and CMV strains by detecting IgG
antibodies to these viruses. However, due to possible
cross-reaction, further studies would need to be per-
formed to differentiate between actual human herpesvi-
ruses and indigenous gibbon herpesviruses.
Results
The results of the serological tests on gibbon sera for anti-
HSV-1, HSV-2, EBV and CMV show evidence of mixed
herpesvirus infections in healthy gibbons as shown in Ta-
ble 2. There were 22 gibbons positive for HSV-1. These
same gibbons were also positive for HSV-2. Anti-herpesvi-
rus antibody was detected in 39 of 78 (50.0%) gibbons
tested. Among these, 16 of 39 (41.0%) had antibody to
HSV-1 and HSV-2, 8 of 39 (20.5%) had antibody to EBV,
8 of 39 (20.5%) had antibody to CMV, 1 of 39 (2.5%) had
antibody to EBV and CMV, 4 of 39 (10.2%) had antibody
to HSV-1, HSV-2, and EBV, 1 of 39 (2.5%) had antibody
to HSV-1, HSV-2, and CMV and 1 of 39 (2.5%) had anti-
body to HSV-1, HSV-2, EBV and CMV. The cut-off value
(COV), mean and range of positive optical density (OD)
were shown in Table 2.
Discussion
Despite the rather limited data on herpesvirus infection in
wild animals, our results showed a high prevalence of
HSV-1 and HSV-2 infection in gibbons, comparable with
previous serological studies on the incidence variation of
herpesvirus infections in different species of apes. Of 24
gibbon serum samples tested, 8 (33.3%) were positive
and reacted more strongly with the HSV-1 antigen than
with any of the other herpesvirus antigens [5].
Both western blot assay and virus neutralization tests were
done with sera from 15 gibbons. Antibodies against HSV-
1 and HSV-2 were detected in four (26.6%) healthy gib-
bons [6]. In addition, neutralizing antibodies against HSV
were found in 16 of the 84 (19.0%) animals in the colony
[3]. Cerebral infarction and myocardial fibrosis were re-
ported in a white-handed gibbon (Hylobates lar), which
was serologically positive for HSV-1 and EBV [7]. Howev-
er, the serological tests can not positively determine if this
was the cause of illness. Most of the gibbons are healthy,
with herpesvirus infection in those animals apparently be-
ing in the latent phase.
Isolation of viruses related to HSV from primates is scarce.
However, a number of primate species, including apes,
have been surveyed for antibodies to many different sim-
ian and related human viruses [5]. These studies have re-
ported that the incidence of herpesvirus antibody in
gorillas, orangutans, and gibbons is very low, whereas
chimpanzees showed a much higher prevalence. In our
study, we found that the prevalence for HSV-1 and HSV-2
was equal (28.2%). It has been reported that both viruses
share a common antigen, which can cause serologic cross-
reaction [8].
Sera obtained from 50 non-human primates and 45 lower
mammals were tested for complement fixation (CF) anti-
bodies to partially purified antigens prepared from virus-
containing cells of Burkitt's lymphoma cultures. All five
non-human primate species tested (chimpanzee, baboon,
cynomolgous, rhesus macaque and African green mon-
key) displayed a high incidence of CF antibodies to EBV,
whereas none of the sera from nine species of laboratory
or domestic animals reacted with this antigen [9]. The
prevalence of herpesvirus antibody among non-human
primate is shown in Table 3.BMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/11
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Since it was not possible to use species-specific antibodies
in the ELISA test, the negative results obtained for gibbons
might be attributable to non-reactivity of their sera with
anti-human IgG. There has been evidence of cross-species
reactivity as both human and non-human (Old World)
primates exhibit close antigenic relationships between
their immunoglobulins. In previous studies, both fluores-
cent-labeled goat anti-human globulin and anti-monkey
globulin reacted well with chimpanzee [10] and non-hu-
man primate globulins [11]. For this reason, goat anti-hu-
man immunoglobulin G (IgG) conjugated with alkaline
phosphatase may be used for both human and non-hu-
man (Old World) primates based on the close antigenic
relationship between their immunoglobulins [12]. Cross-
reactivity has also been reported between human and
monkey herpesviruses [13]. Hence, it is important to de-
termine whether the antibodies detected in the gibbons in
this study are actually directed against human herpesvi-
ruses (HSV-1, HSV-2, EBV and CMV) or other related vi-
ruses. To resolve this problem, ELISA assays using human
herpesvirus and monkey herpesvirus infected cell antigens
could be used. The non-human primate herpesviruses are
much more similar to each other than to human herpes-
viruses. Therefore, the sera will react more strongly with
Table 2: Evidence of serological of herpesviruses (HSV-1, HSV-2, EBV and CMV) infection in healthy gibbons (n = 78 cases).
Herpesvirus Serological markers Positive serological marker Cut-off value Mean positive OD.
No. (%) (COV) Range
HSV-1 22 (28.2) 0.118 0.591
0.286–0.692
HSV-2 22 (28.2) 0.093 0.361
0.137–0.607
EBV 14 (17.9) 0.143 0.395
0.203–0.653
CMV 11 (14.1) 0.085 0.213
0.106–0.375
Herpesvirus mixed infection
HSV-1 and HSV-2 16 (20.5) -
HSV-1, HSV-2 and EBV 4 (5.1) -
HSV-1, HSV-2 and CMV 1 (1.3) -
HSV-1, HSV-2, EBV and CMV 1 (1.3) -
EBV and CMV 1 (1.3) -
Table 3: Number of animals serological positive/total to herpesviruses in non-human primate sera.
Species Tested method HSV-1 HSV-2 EBV CMV
Gorilla [5] ELISA, Immunoblot 49/53(92.5%) 4/53 (7.5%) - -
Chimpanzee [5] ELISA, Immunoblot 2/38 (5.3%) 5/38(13.2%) - -
Orangutan [5] ELISA, Immunoblot 5/70 (7.1%) - - -
Gibbon [5] ELISA, Immunoblot 8/24 (33.3%) - - -
Chimpanzee [5] Complement-Fixation - - 10/10 (100%) -
Baboon [9] Complement-Fixation - - 2/10 (20%) -
Cynomolgous [9] Complement-Fixation - - 10/10 (100%) -
Rhesus [9] Complement-Fixation - - 6/9 (66.7%) -
African Green [9] Complement-Fixation - - 9/10 (90%) -
Rhesus [14] Serum neutralization 67/164 (40.9%) - - -
Dot-immunobinding 77/164 (47.0%) - - -
Chimpanzee [14] Fluorescent antibody - - 2/8 (25%)
Dot-immunobinding - - - 5/8 (62.5%)
Gibbon (our study) ELISA 22/78 (28.2%) 22/78 (28.2%) 11/78 (14.1%) 14/78 (17.9%)BMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/11
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the human than with the non-human primate herpesvi-
rus, suggesting that the gibbon is infected with a human
herpesvirus or vice versa.
The animals we screened were at high risk of contracting
herpesviruses from humans. For example, hand rearing of
gibbon infants by zoo personnel would provide ample
opportunity for human herpesvirus transmission to gib-
bons. Moreover, the exclusive HSV serotypes within spe-
cies suggests that these viral infections may have
originated from a common source within a species, with
subsequent spread from animal to animal, rather than
from isolated human-to-gibbon transmissions. Accord-
ingly, HSV-2 infections have been observed to spread
from chimpanzee to chimpanzee [5].
Based on the high level of cross-reactivity expected to exist
between the human herpesviruses likely to be contracted
by animals in captivity and any indigenous gibbon virus-
es, it is difficult to draw any concrete conclusions from se-
rological studies alone. The most convincing approach
toward identification of an indigenous gibbon herpesvi-
rus would be virus isolation from seropositive animals
and subsequent molecular characterization.
Conclusions
It can be stated that infections with herpesvirus-like virus-
es are relatively common in gibbons. The viruses found in
these gibbons are either human herpesviruses or indige-
nous gibbon herpesviruses that are antigenically similar to
human herpesviruses. Further studies on molecular char-
acterization of gibbon herpesviruses should be performed
in order to arrive at concrete conclusions.
Materials and methods
Seventy-eight healthy gibbons kept at the Krabok Koo
Wildlife Breeding Center, Royal Forest Department, Cha-
Cheng-Sao province, Thailand were included in the study.
All of the animals examined, although born in the wild,
were raised by humans and have since been kept in cap-
tivity at the National Wildlife Research Center. Demo-
graphic data for the gibbons are shown in Table 1. Blood
samples were obtained by femoral venipuncture during a
brief period of anesthesia by Ketamine hydrochloride, ac-
cording to routine health care procedures. The sera were
separated by centrifugation and stored at -70°C until fur-
ther analysis.
As no screening test is available for gibbon herpesviruses,
screening for serum antibodies against HSV-1, HSV-2, EBV
and CMV was performed by ELISA using the HUMAN-ELI-
SA-Antibodies-Test (Human, Wiesbaden, Germany). The
procedure applied followed the manufactured recom-
mendations. Calculation of control values and cut-off,
mean absorbance values of the negative control in wells
B1 and C1 (MNC) and the positive control in wells D1
and E1 (MPC) are calculated according to: MNC =
[A450(B1)+A450(C1)]/2; MPC = [A450(D1)+A450(E1)]/2.
The cut-off value (COV) is calculated using the formula:
COV = MNC+0.1×  MPC. The OD more than COV is con-
sidered positive.
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